Drug Trial Radar · NCT00660179
Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
Last checked: Nov 19, 2026Latest source record: Sep 28, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
742
Actual
Start
May 2008
Primary completion
Mar 2012
Study completion Apr 2012
Sponsor
- Lead sponsor
- ActelionJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Apr 17, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The AC-055-302/SERAPHIN study will be an event-driven Phase III study, comparing two different doses of macitentan (ACT-064992) (3 and 10 mg) vs placebo in patients with symptomatic PAH. The main study objective is to demonstrate that macitentan (ACT-064992) prolongs time to the first morbidity or mortality event, and to evaluate the benefit/risk profile of macitentan (ACT-064992) in the treatment of patients with symptomatic PAH.
Conditions
- Pulmonary Arterial Hypertension
Interventions
macitentan (ACT-064992)Drug
Tablet, 3 mg dosage, once daily
macitentan (ACT-064992)Drug
Tablet, 10 mg dosage, once daily
placeboDrug
Matching placebo, once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to First Confirmed Morbidity or Mortality Event up to the End of Treatment (Kaplan-Meier Estimate of Patients Without a Morbidity or Mortality Event)Time frame: Up to end of treatment (data presented up to month 36)
Locations
153 sites in 38 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Arizona Pulmonary Specialists
Pheonix, Arizona
GLVA Healthcare Center
Los Angeles, California
University of California, San Diego
San Diego, California
Santa Barbara Cottage Hospital
Santa Barbara, California
Liu Center for Pulmonary Hypertension
Torrance, California
University of Colorado Health Sciences Center
Denver, Colorado
Mayo Clinic, Jacksonville
Jacksonville, Florida
Emory University Hospital - McKelvey Center for Lung Transplantation & Pulmonary Vascular Disease
Atlanta, Georgia
Pulmonary & Critical Care of Atlanta
Atlanta, Georgia
Southeastern Lung Care
Decatur, Georgia
University of Chicago Hospitals
Chicago, Illinois
University of Iowa
Iowa City, Iowa
University of Kansas Medical Center
Kansas City, Kansas
Kentuckiana Pulmonary Associate, PLLC
Louisville, Kentucky
Medical Center of Louisiana at New Orleans
New Orleans, Louisiana
Maine Medical Center
Portland, Maine
University of Maryland School of Medicine
Baltimore, Maryland
Boston University School of Medicine
Boston, Massachusetts
Pulmonary/Critical Care Division/Tufts New England Medical Center
Boston, Massachusetts
University of Michigan
Ann Arbor, Michigan
Washington University School of Medicine
St Louis, Missouri
University of NJ - Robert Wood Johnson Medical School
New Brunswick, New Jersey
Columbia University Medical Center - Pediatric Cardiology
New York, New York
Duke University Medical Center
Durham, North Carolina
University of Cincinnati Ohio Heart Health Center
Cincinnati, Ohio
Ohio State University
Columbus, Ohio
Vanderbilt University Medical Center
Nashville, Tennessee
University of Texas Medical Center - St. Paul University
Dallas, Texas
Baylor College of Medicine and the Methodist Hospital
Houston, Texas
Dept. of Pulmonary Medicine - Latter Day Saints Hospital
Salt Lake City, Utah
Sentara Hospital T/A Sentara Cardiovascular Research Institute
Norfolk, Virginia
Comprehensive Cardiovascular Care Group
Milwaukee, Wisconsin
Fundacion Favaloro
Buenos Aires, Argentina
Hospital Britanico
Buenos Aires, Argentina
Sanatorio MITRE
Buenos Aires, Argentina
SANATORIO OTAMENDI y MIROLI
Buenos Aires, Argentina
Htal Italiano Cordoba
Córdoba, Argentina
Htla privado de Cordoba
Córdoba, Argentina
Instituto Cardiologia Corrientes
Corrientes, Argentina
Showing 40 of 153 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.